Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 29

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 29
---
.0% of the gross proceeds from the sale of our common stock on our
behalf pursuant to the Sales Agreement. We have also agreed to reimburse A.G.P. for its reasonable and documented out-of-pocket
expenses (including but not limited to the reasonable and documented fees and expenses of its legal counsel) in an amount not to
exceed $50,000 and up to an additional $5,000 per quarter (and in no event more than $20,000 per fiscal year) for maintenance. We
have also agreed to reimburse A.G.P. for its reasonable and documented out-of-pocket expenses (including but not limited to the
reasonable and documented fees and expenses of its legal counsel) in an amount not to exceed $10,000 for each program
“refresh” (filing of a new registration statement, prospectus, or prospectus supplement relating to the common shares
and/or an amendment to the Sales Agreement).

<div align='center'>S-14</div>

We estimate that the total
expenses for this offering, excluding compensation payable to A.G.P. and certain expenses reimbursable to A.G.P. under the terms of the
sales agreement, will be approximately $70,000. The remaining sales proceeds, after deducting any expenses payable by us and any transaction
fees imposed by any governmental, regulatory, or self-regulatory organization in connection with the sales, will equal our net proceeds
for the sale of such common stock.

Regulation M

In connection with the sale
of the common stock on our behalf, A.G.P. will be deemed to be an “underwriter” within the meaning of the Securities Act,
and the compensation of A.G.P. will be deemed to be underwriting commissions or discounts.

A.G.P. will not engage in
any market making activities involving our common stock while the offering is ongoing under this prospectus supplement if such activity
would be prohibited under Regulation M or other anti-manipulation rules under the Securities Act. As our sales agent, A.G.P. will not
engage in any transactions that stabilizes our common stock.

Indemnification

We have agreed to indemnify
A.G.P. against certain civil liabilities, including liabilities under the Securities Act and the Exchange Act, and to contribute to payments
that the A.G.P. may be required to make in respect of such liabilities.

Listing

Our common stock is listed on The Nasdaq Global
Market under the symbol “IXHL.”

Other Relationships

A.G